Status:
COMPLETED
Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care Delivery
Lead Sponsor:
Indiana University
Conditions:
Vulvar Cancer
Ovarian Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to help test an idea designed to foster more supportive talk between providers (doctors or nurse practitioners), patients, and caregivers during an outpatient oncology app...
Detailed Description
This pilot study focuses on an intervention (freelisting) designed to elicit supportive oncology communication intentions among the patient-caregiver-provider triad prior to an outpatient oncology enc...
Eligibility Criteria
Inclusion
- patients will:
- be adult women with an incurable gynecologic cancer (i.e., evidence of refractory/progressive disease after first-line treatment or recurrent disease),
- not be receiving specialty palliative care or hospice,
- read/speak English, and
- be able to provide written informed consent.
- caregivers will:
- identify as the individual who is primarily involved in the patient's care,
- be able to attend the oncology encounter,
- read/speak English, and
- be able to provide written informed consent.
- providers will:
- specialize in gynecologic oncology, and
- provide outpatient care at IUSCCC gynecologic oncology clinic.
Exclusion
- patients and/or caregivers will be excluded if either one or both demonstrate:
- cognitive impairment, or
- speech/hearing difficulties precluding participation.
Key Trial Info
Start Date :
June 14 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 23 2025
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05995860
Start Date
June 14 2023
End Date
January 23 2025
Last Update
January 28 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IU Health Joe and Shelly Schwarz Cancer Center
Carmel, Indiana, United States, 46032
2
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States, 46202